Tag
Studies, research synthesis, data interpretation and methodological questions.
Tuns summarizes reporting on British Columbia's euthanasia oversight records, distinguishing documentation errors from more serious compliance concerns. The article presents critics' arguments for stronger independent oversight and more transparent reporting of enforcement actions.
Read →Sielicki examines a Noble Predictive Insights poll commissioned for Center Square about mailed abortion pills. She reports support for online prescribing alongside respondents' safety concerns and discusses objections from pro-life advocates.
Read →Mia Steupert compares national post-Dobbs abortion estimates from different data sources. The report discusses how interstate travel, mail-order medication, and changing state laws complicate estimates of abortion incidence.
Read →Flanders argues that abortion pills should not be described as healthcare because their intended outcome ends prenatal life. She also presents safety and regulatory claims that require medical and primary-source review before republication as factual guidance.
Read →Novielli analyzes figures on certified abortion-pill prescribers in relation to the broader physician workforce. She discusses reported reasons for not prescribing, including legal concerns, safety questions, and access to surgical backup.
Read →National Right to Life welcomes a Senate committee investigation into oversight by mifepristone manufacturers. The release argues that the findings support additional accountability measures and the proposed APPLE Act.
Read →New discusses Guttmacher estimates of interstate abortion travel and medication provision, including early 2026 data. He argues that greater telehealth use helps explain reduced travel while maintaining that state restrictions still influence birth outcomes.
Read →Jeff Pauls and Liam Seigler discuss Vitae Foundation research about men's responses to pregnancy and their influence on abortion decisions. They consider how pregnancy-help messaging and services might better engage fathers.
Read →The authors review Wyoming's 2025 abortion report and contrast its reported count with outside estimates. The analysis explains that provider location, mailed medication, and data-collection methods can produce different totals.
Read →The authors compare South Dakota's official 2025 abortion reporting with estimates of medication sent into the state. They distinguish reported procedures from mailed regimens and caution that these measures do not describe the same population or outcome.
Read →This analysis describes a decline in abortions reported by South Carolina and reviews the distribution of abortion methods. The authors explain that the state report does not capture every abortion obtained by residents, including some medication supplied from outside the state.
Read →The authors analyze Nebraska's reported 2025 abortions and compare the state figures with estimates from other research organizations. They emphasize that differences in mail-order abortion coverage and abortions obtained outside the state complicate direct comparisons.
Read →The authors examine Maine's reported 2025 abortions and describe an increase from the prior year. They compare official reporting with broader estimates and discuss the effect of differing treatment of mailed abortion medication.
Read →The analysis explains that Arkansas reported no in-state abortions for 2025 while other organizations estimated medication shipments into the state. The authors stress that a zero in the state report does not establish that no Arkansas residents obtained abortions.
Read →John Grondelski discusses state attorneys general's request for scrutiny of possible environmental effects associated with abortion medication. He argues for further investigation, but the article does not establish that drinking-water exposure causes the harms it raises.
Read →New reviews the Society of Family Planning's final 2025 estimates and emphasizes the growing share attributed to telehealth. His commentary argues that mailed medication weakens state abortion restrictions and calls for federal policy changes.
Read →Waters examines falling birth rates alongside the growth of IVF and fertility technology. She argues for a pro-life approach that addresses underlying infertility while scrutinizing embryo creation, loss and industry incentives.
Read →Guest host Sarah Bowen interviews Jon Merwarth about growing a Pennsylvania pregnancy center and later advising other centers. They discuss leadership, state-level collaboration, and using local maternal-health information to identify service gaps.
Read →Moira Gaul discusses national surveys of pregnancy centers conducted through Charlotte Lozier Institute. She and Bennett consider the services centers report providing and how those services support families.
Read →National Right to Life criticizes a Supreme Court order allowing mail distribution of mifepristone to continue while litigation remains unresolved. The organization calls for stronger in-person oversight and adverse-event reporting, presenting its safety concerns as reasons to restore earlier restrictions.
Read →Van Maren examines a Research Co. poll about health professionals' ability to object to assisted death and abortion. He argues for conscience protections and expresses concern about the level of public support reported in the survey.
Read →George Delgado discusses his book and his advocacy of progesterone treatment after mifepristone. The interview presents his claims about abortion-pill reversal, informed consent, and medical ethics rather than an independent evaluation of the evidence.
Read →Van Maren criticizes Ontario instructions for recording the underlying condition rather than assisted death in mortality statistics. He argues that this convention obscures the role of euthanasia in deaths and affects public understanding of the data.
Read →Tabitha Goodling reports on increased services provided by Ohio pregnancy centers and the economic pressures faced by their clients. The article combines coalition data, comments from Savannah Marten, and a client account to describe the need for material and relational support.
Read →Michael New interprets abortion estimates for the first half of 2025 and highlights growth in telehealth provision. He argues that public funding and access to abortion medication affect incidence and urges pro-life policymakers to address those factors.
Read →O'Bannon discusses conflicting explanations for the absence of an expected federal abortion-surveillance report. He also describes longstanding gaps in state reporting and the additional difficulty of counting abortions associated with interstate medication provision.
Read →Trudden reports increased contacts with Heartbeat International's Option Line and Abortion Pill Rescue Network during 2025. She argues that these organizational figures and client accounts demonstrate demand for accessible counseling and local pregnancy support.
Read →Hazzard compares recent Gallup abortion polling with the surge in abortion-rights sentiment around the Dobbs decision. She interprets the changes as evidence that the initial public backlash is receding, while revisiting her earlier prediction.
Read →Randall O'Bannon critiques a study of clinician relocation after Dobbs, questioning what its sample can establish about broader maternal-care availability. He argues that movement by abortion-only providers should not automatically be interpreted as a general loss of obstetric services.
Read →Schadenberg summarizes the Netherlands' reported 2024 euthanasia totals and highlights an increase in cases involving psychiatric conditions. He raises concerns about the implications for younger patients and for countries considering similar laws.
Read →